Category: Pharmaceuticals
Global Pharmaceuticals
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More
-
IoT in Intelligent Transportation System
... is expected to reach US$543.4 Billion by 2030, growing at a CAGR of 20.0% over the analysis period 2023-2030. Hardware Component, one of the segments analyzed in the report, is expected to record a 21.7% ... Read More
-
Child Resistant Closures
... by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Push and Turn Closure, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.8 ... Read More
-
Counter Terror and Public Safety Technology
... the year 2023, is expected to reach US$532.3 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2023-2030. Cyber Security Technology, one of the segments analyzed in the report, is expected ... Read More
-
Flea and Tick Products
... reach US$11.2 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Chewable Products, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach ... Read More
-
Global Musculoskeletal System Disorder Market Research Report 2024
... of 4.19% during the forecast period 2024-2030. North American market for Musculoskeletal System Disorder is estimated to increase from $ 77023 million in 2023 to reach $ 100034 million by 2030, at a CAGR of ... Read More
-
Alzheimers Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 3.52 billion in 2022, and the market is now projected to grow from USD 3.69 billion in 2023 to USD 5.21 billion by 2030, exhibiting a CAGR of 5.1% during the forecast period of 2023-2030. ... Read More
-
Global Electric Cannabis Grinder Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 2066 million by 2030 with a CAGR of 7.2% during review period. Legalization of cannabis in several countries over past few years have ... Read More
-
Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Report, History and Forecast 2019-2030
... reach $ 780.46 million by 2030, at a CAGR of 3.64% during the forecast period of 2024 through 2030. North American market for Chlorhexidine Gluconate Product for Patient Skin Antisepsis was valued at $ 217.01 ... Read More
-
Impact of Covid-19 on Pharmaceuticals Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... of Covid-19 on the pharmaceuticals market size was valued at USD 1,494.67 billion in 2021, and the market is now projected to grow from USD 1,585.05 billion in 2022 to USD 2,401.22 billion by 2029, ... Read More
-
Global Oral Rehydration Solution Market Research Report 2024
... of 5.34% during the forecast period 2024-2030. North American market for Oral Rehydration Solution is estimated to increase from $ 275.7 million in 2023 to reach $ 384.35 million by 2030, at a CAGR of ... Read More
-
Oncology Based In-Vivo CRO
... reach US$2.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and ... Read More
-
Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... released a research report titled “Global Epilepsy Therapeutics Market (2024 Edition)” which provides an analysis of the Global Epilepsy Therapeutics industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation), By ... Read More
-
Orphan Drugs
... at a CAGR of 11.9% over the analysis period 2023-2030. Biologic Drugs, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$286.3 Billion by the end of ... Read More
-
Pesticide Inert Ingredients
... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Emulsifiers, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$3.3 Billion by the ... Read More
-
Brain Computer Interface
... by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Invasive BCI, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.5 Billion by ... Read More
-
Microwave Ablation
... at a CAGR of 13.0% over the analysis period 2023-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$215.5 Million by the end ... Read More
-
Sodium Alginate
... at a CAGR of 4.9% over the analysis period 2023-2030. Stabilizers Application, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$137.4 Million by the end of ... Read More
-
Venturi Masks
... at a CAGR of 11.5% over the analysis period 2023-2030. COPD Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Insulin Pens
... at a CAGR of 7.1% over the analysis period 2023-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$11.6 Billion by the end ... Read More
-
Soft Tissue Repair
... by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Fixation Products, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$19.6 Billion by ... Read More
-
Diabetic Shoes
... at a CAGR of 8.1% over the analysis period 2023-2030. Online Distribution Channel, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$10.6 Billion by the end ... Read More
-
Desmopressin
... of 5.5% over the analysis period 2023-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More
-
Natural Antioxidants
... at a CAGR of 5.9% over the analysis period 2023-2030. Vitamin C, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Acne Drugs
... at a CAGR of 6.8% over the analysis period 2023-2030. Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$9.6 Billion by the end of ... Read More
Research Assistance
